EyeYon Medical
Develops and brings to market exclusive medical ophthalmic devices, which offer relief to the unmet clinical needs of millions of patients.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
$25.0m | Series C | ||
| Total Funding | 000k | ||
Related Content
EyeYon Medical is a pioneering company in the field of ophthalmology, specializing in the development and commercialization of innovative therapeutic contact lenses. The company's flagship product, the Hyper-CL lens, is designed to treat corneal edema and other ocular conditions, significantly improving visual acuity for patients. EyeYon Medical operates in the medical device market, primarily serving ophthalmologists and their patients in Europe and the USA, where the product is CE certified and FDA 510k cleared. The business model revolves around the sale of these specialized lenses to healthcare providers and clinics, generating revenue through direct sales and distribution partnerships. The company focuses on providing effective, non-invasive solutions for eye care, aiming to enhance patient quality of life and satisfaction.
Keywords: ophthalmology, therapeutic lenses, corneal edema, visual acuity, medical device, CE certified, FDA cleared, non-invasive, patient outcomes, healthcare providers.